Reports

Ideas That Generate Results

Preventive Asthma Drug Market Outlook 2020

Preventive Asthma Drug Market Outlook 2020

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Dec, 2015| No. of Pages : 45

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1500.00
CD-ROM Mail Delivery
US$ 1700.00
Hard Copy Mail Delivery
US$ 1700.00
Electronic Access - Multi-User License
US$ 2200.00

List of Figures:

Figure 3-1: Diagnostic Flow - Chart for Asthma in Clinical Practices 
Figure 5-1: Global - Preventive Asthma Drugs Market (Billion US$), 2014-2020
Figure 6-1: Global - Preventive Asthma Drugs Market by Different Types of Drugs (%), 2014
Figure 6-2: Global - Preventive Asthma Drugs Market by Geography (%), 2014
Figure 8-1: Share of Major Players in Preventive Asthma Drugs Market (%), 2014
Figure 8-2: Glaxosmithkline Plc - Revenue by Geographical Regions (%), 2014
Figure 8-3: Astrazeneca - Revenue by Geographical Regions (%), 2014 
Figure 8-4: Merck - Revenue by Geographical Regions (%), 2014
Figure 8-5: Roche - Revenue by Geographical Regions (%), 2014
Figure 8-6: Novartis - Revenue by Geographical Regions (%), 2014

 

List of Tables:

Table 8-1: Revenues of Top Selling Preventive Asthma Drugs (Million US$), 2014
Table 8-2: Glaxosmithkline Plc - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 8-3: Astrazeneca - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 8-4: Merck - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 8-5: Roche: Revenue by Business Segments (Billion US$), 2013 & 2014 
Table 8-6: Novartis - Revenue by Business Segments (Billion US$), 2013 & 2014

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.